Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Overweight women with PCOS are more likely to have excess male hormones.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Androgens can cause hair growth in some areas and hair loss on the scalp.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Hirsutism causes significant psychological distress in women.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.